home / stock / iccm / iccm news

ICCM News and Press, IceCure Medical Ltd. From 10/12/21

Stock Information
Company Name: IceCure Medical Ltd.
Stock Symbol: ICCM
Market: NASDAQ
Website: icecure-medical.com
Menu
ICCM ICCM Quote ICCM Short ICCM News ICCM Articles ICCM Message Board
Get ICCM Alerts

News, Short Squeeze, Breakout and More Instantly...
ICCM - IceCure Medical Announces Updated Regulatory Strategy in China for the IceSense3® System to Treat Cancerous Tumors with Cryoablation

IceCure Medical Announces Updated Regulatory Strategy in China for the IceSense3® System to Treat Cancerous Tumors with Cryoablation IceCure submitted an amendment to the registration certificate granted for the IceSense3 System by China's NMPA, which will allow IceCure to ...
ICCM - Protagonist Therapeutics, Adamas Pharmaceuticals leads healthcare gainers; Voyager Therapeutics, Protalix BioTherapeutics among major losers

Gainers: Protagonist Therapeutics (NASDAQ:PTGX) +82%, Adamas Pharmaceuticals (NASDAQ:ADMS) +74%, Flexion Therapeutics (NASDAQ:FLXN) +62%, Evelo Biosciences (NASDAQ:EVLO) +16%, Progenity (NASDAQ:PROG) +16%. Losers: Voyager Therapeutics (NASDAQ:VYGR)...

ICCM - IceCure Medical Reports Financial Results for the First Half of 2021 and Recent Operating Highlights

IceCure Medical Reports Financial Results for the First Half of 2021 and Recent Operating Highlights PR Newswire CAESAREA, Israel , Sept. 23, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of the next...

ICCM - IceCure Medical Announces First Peer Reviewed Publication for the 3-Year Interim Analysis of the ICE3 Trial on Cryoablation of Low-Risk, Early-Stage Breast Cancer

IceCure Medical Announces First Peer Reviewed Publication for the 3-Year Interim Analysis of the ICE3 Trial on Cryoablation of Low-Risk, Early-Stage Breast Cancer Dr. Richard Fine to present findings at the Mayo Clinc Conference "Breast Cancer Care: Innovation, Disruptive Techno...
Previous 10 Next 10